Forian Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 159 out of 482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 2.10.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Forian Inc's Score
Industry at a Glance
Industry Ranking
159 / 482
Overall Ranking
268 / 4521
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Forian Inc Highlights
StrengthsRisks
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
Growing
The company is in a growing phase, with the latest annual income totaling USD 20.15M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Undervalued
The company’s latest PE is -76.42, at a low 3-year percentile range.
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.